We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CDIX market cap is 4.47B. The company's latest EPS is USD 0.0025 and P/E is 1300.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.54M | 3.45M | 10.01M | 12M | 11.85M |
| Operating Income | -1.32M | -1.8M | 1.63M | 1.69M | 5.19M |
| Net Income | -6.36M | -2.91M | -410k | -5.43M | 2.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.3M | 4.93M | 11.16M | 13.35M | 20.75M |
| Total Liabilities | 11.21M | 13.05M | 8.38M | 10.2M | 14.13M |
| Total Equity | -5.91M | -8.12M | 2.78M | -1.47M | 731k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -442k | -114k | -1.04M | -1.14M | -1.72M |
| Investing | 32k | N/A | -2.32M | 1,000 | N/A |
| Financing | 718k | 1.15M | 3.68M | 789k | 2.37M |
| Market Cap | 4.47B |
| Price to Earnings Ratio | 1300.00 |
| Price to Sales Ratio | 244.36 |
| Price to Cash Ratio | 3.25k |
| Price to Book Ratio | 438.57 |
| Dividend Yield | - |
| Shares Outstanding | 893.47M |
| Average Volume (1 week) | 1.32k |
| Average Volume (1 Month) | 1.32k |
| 52 Week Change | -33.33% |
| 52 Week High | 105.00 |
| 52 Week Low | 1.50 |
| Spread (Intraday) | 4.5 (60%) |
| Company Name | Cardiff Lexington Corporation (PK) |
| Address |
601 s. rancho dr las vegas, nevada 89106 |
| Website | https://www.cardifflexington.com |
| Industry | offices of medical doctors (8011) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
